Cuban health ministry ( MINSAP by its Spanish acronym)) reported today that 9 970 913 people (90 %) have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.»
The Cuban Institute of Meteorology (INSMET, in Spanish) on Saturday reported that the recent climatic event that hit the Caribbean country may become a tropical phenomenon on Sunday.»
Cuban experts refine the innovative GNSS-R technology installed in Santiago de Cuba to include it in the country's Tsunami Warning System, in charge of the National Center for Seismological Research (Cenais).»
Shanghai authorities say they are taking steps on Wednesday towards reopening China’s largest city after a two-month COVID-19 lockdown that has set back the national economy and confined millions of people to their homes.»
The Cuban Biotechnological and Pharmaceutical Industries Group (BioCubaFarma) is advancing today a strategy aimed at the production of 525 medicines in the midst of the limitations imposed by the U.S. economic blockade. »
In the United States, the Centers for Disease Control and Prevention published a study finding more than one in five adults who survive COVID-19 go on to experience at least one symptom of “long COVID” -- with problems including fatigue; heart, lung and kidney damage; cognitive decline; blood clots and more. »
World Health Organization (WHO) Director General Tedros Adhanom on Wednesday thanked Cuba for its support for several nations during the most difficult times of the Covid-19 pandemic. »
In 2010, the World Organization of Family Doctors (WONCA) proposed the creation of World Family Doctor Day to highlight the importance and contribution of these professionals to health systems worldwide, but since 1984 Cubans, from our own experience, we already valued this task very much.»
The inauguration in Iran of an anti-covid vaccine production plant called PastoCorona took place on Sunday.»
The Cuban scientific community is currently preparing several clinical trials aimed at children under two years of age, who have not received a SARS-CoV-2 vaccine.»
Escambray ENGLISH EDITION